年龄与合并症对骶神经调节使用的影响
本研究分析2012至2014年一家高手术量机构356例骶神经刺激患者的数据库,评估年龄与刺激试验结局、装置植入及治疗持久性的关联。结果显示试验成功率在各年龄段无差异,女性及急迫性尿失禁患者试验成功几率更高,年龄与翻修风险降低相关,年龄本身不应负面预测骶神经刺激反应。
要点
- 356例患者中,非梗阻性尿潴留和尿频尿急患者较急迫性尿失禁患者年轻。
- 一期试验和经皮神经评估试验的成功率在各年龄组间无差异(p=0.51和0.84)。
- 年龄每增加1岁,翻修几率降低3%(OR 0.97,95%CI 0.95-0.98,p<0.0001)。
核心结论
- 与既往研究不同,老年患者在刺激试验中的骶神经刺激反应无差异,植入率也无差异。
- 年龄对装置翻修有适度保护作用,提示年龄本身不应负面预测骶神经刺激反应。
研究设计与样本
- 回顾性分析2012至2014年一家高手术量机构所有骶神经刺激手术的数据库,共356例患者。
- 评估年龄与骶神经刺激适应症、试验刺激成功、装置翻修和装置取出的关联。
主要发现
- 非梗阻性尿潴留和尿频尿急患者较急迫性尿失禁患者年轻。
- 一期试验和经皮神经评估试验的刺激成功率在各年龄组间无差异(p=0.51和0.84)。
- 女性试验成功几率高于男性(OR 2.97,95%CI 1.32-6.04,p=0.009)。
- 急迫性尿失禁试验成功几率高于尿频尿急(OR 3.02,95%CI 1.39-6.50,p=0.006)。
- 分析患者中共有119例手术翻修(包括电池更换)和53例取出。
关键数值与推荐
- 年龄每增加1岁,翻修风险降低3%(OR 0.97,95%CI 0.95-0.98,p<0.0001)。
- 年龄不影响取出,但体重指数每增加1个单位,取出几率降低5%(OR 0.95,95%CI 0.91-0.98)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated the influence of patient age on sacral nerve stimulation trial outcomes, device implantation and treatment durability. MATERIALS AND METHODS: We analyzed a database of all sacral nerve stimulation procedures performed between 2012 and 2014 at a high volume institution for associations of patient age with sacral nerve stimulation indication, trial stimulation success, device revision and device explantation. RESULTS: In a cohort of 356 patients those with nonobstructive urinary retention and urgency-frequency were younger than patients with urgency urinary incontinence. Trial stimulation success did not differ by age in stage 1 and percutaneous nerve evaluation trials (p = 0.51 and 0.84, respectively). Logistic regression identified greater odds of trial success in females compared to males (OR 2.97, 95% CI 1.32-6.04, p = 0.009) and for urgency urinary incontinence compared to urgency-frequency (OR 3.02, 95% CI 1.39-6.50, p = 0.006). In analyzed patients there were 119 surgical revisions, including battery replacement, and 53 explantations. Age was associated with a decreased risk of revision with 3% lower odds per each additional year of age (OR 0.97, 95% CI 0.95-0.98, p <0.0001). While age did not influence explantation, for each body mass index unit there was a 5% decrease in the odds of explantation (OR 0.95, 95% CI 0.91-0.98). CONCLUSIONS: In contrast to previous studies, older patients experienced no difference in the sacral nerve stimulation response in stimulation trials and no difference in the implantation rate. Furthermore, age was modestly protective against device revision. This suggests that age alone should not negatively predict sacral nerve stimulation responses.
引用
- Faris AER, Gill BC, Pizarro-Berdichevsky J, et al. Impact of Age and Comorbidities on Use of Sacral Neuromodulation. J Urol. 2017. PMID: 28192077. doi:10.1016/j.juro.2017.02.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。